About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Improving Prospective Memory Via Telehealth | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05129293

Improving Prospective Memory Via Telehealth

Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been sho...

Lead sponsor: Trinity Health Of New England•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Trinity Health Of New England

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinical diagnosis of MS
•Able to read, write, and speak in English
•Between the ages of 18 and 60
•All genders
•No history of other serious neurologic or psychiatric illness, including drug or alcohol misuse
•No relapses within the past two months
•Access to the Internet and a web camera
•Not enrolled in a cognitive rehabilitation program within the past six months
•Self-reported issues "remembering places they have to be" and "things they have to do"

Exclusion Criteria

•No diagnosis of MS
•Unable to complete the study protocol due to language barriers
•Younger than 18 or older than 61
•No gender exclusions
•History of other serious neurologic or psychiatric illness, including drug or alcohol misuse
•Had a relapse within the past two months
•No access to the Internet and/or a web camera
•Currently enrolled or enrolled in a cognitive rehabilitation program within the past six months
•No self-reported issues with "remembering places they have to be" or "things they have to do"

Related studies

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 2

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490 · Multiple Sclerosis Spasticity

RECRUITINGPhase 3

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019 · Secondary Progressive Multiple Sclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 18, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment35

Start dateNov 2021

Last updatedOct 18, 2024

Condition

Multiple Sclerosis

Locations shown

Mount Sinai Rehabilitation Hospital

Hartford, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 18, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions